Strata Critical Medical, Inc. (SRTA)
NASDAQ: SRTA · Real-Time Price · USD
4.350
-0.050 (-1.14%)
At close: Dec 5, 2025, 4:00 PM EST
4.410
+0.060 (1.38%)
After-hours: Dec 5, 2025, 5:56 PM EST
Strata Critical Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | 2020 - 2019 |
| Revenue | 268.62 | 248.69 | 225.18 | 146.12 | 67.16 | 50.53 | Upgrade
|
| Revenue Growth (YoY) | 70.11% | 10.44% | 54.11% | 117.58% | 32.92% | 115.61% | Upgrade
|
| Cost of Revenue | 204.82 | 189.77 | 183.06 | 123.85 | 54.31 | 40.01 | Upgrade
|
| Gross Profit | 63.8 | 58.92 | 42.12 | 22.28 | 12.85 | 10.52 | Upgrade
|
| Selling, General & Admin | 85.59 | 82.42 | 82.18 | 67.23 | 42.96 | 32.66 | Upgrade
|
| Research & Development | 3.51 | 3.18 | 4.63 | 5.55 | 2.16 | 1.68 | Upgrade
|
| Operating Expenses | 89.1 | 85.61 | 86.8 | 72.77 | 45.11 | 34.34 | Upgrade
|
| Operating Income | -25.3 | -26.69 | -44.68 | -50.5 | -32.26 | -23.82 | Upgrade
|
| Interest & Investment Income | 5.19 | 7.21 | 8.44 | 3.43 | 0.74 | 0.46 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.25 | -0.85 | 2.13 | 24.23 | -9.15 | -20.06 | Upgrade
|
| EBT Excluding Unusual Items | -20.36 | -20.33 | -34.11 | -22.84 | -40.67 | -43.42 | Upgrade
|
| Merger & Restructuring Charges | -2.64 | -1.48 | - | -3.03 | - | -0.27 | Upgrade
|
| Gain (Loss) on Sale of Investments | -5.2 | - | 0.01 | -2.16 | - | - | Upgrade
|
| Asset Writedown | - | -5.76 | -20.75 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | -2.68 | - | - | - | Upgrade
|
| Pretax Income | -33.51 | -27.56 | -57.54 | -28.03 | -40.67 | -43.7 | Upgrade
|
| Income Tax Expense | -0.26 | -0.26 | -1.47 | -0.77 | -3.75 | -3.64 | Upgrade
|
| Net Income | 40.39 | -27.31 | -56.08 | -27.26 | -36.92 | -40.05 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 0.02 | - | Upgrade
|
| Net Income to Common | 40.39 | -27.31 | -56.08 | -27.26 | -36.94 | -40.05 | Upgrade
|
| Shares Outstanding (Basic) | 81 | 77 | 74 | 71 | 54 | 43 | Upgrade
|
| Shares Outstanding (Diluted) | 81 | 77 | 74 | 71 | 54 | 43 | Upgrade
|
| Shares Change (YoY) | 5.22% | 5.41% | 3.21% | 31.65% | 26.18% | 70.10% | Upgrade
|
| EPS (Basic) | 0.50 | -0.35 | -0.76 | -0.38 | -0.68 | -0.93 | Upgrade
|
| EPS (Diluted) | 0.50 | -0.35 | -0.76 | -0.38 | -0.68 | -0.93 | Upgrade
|
| Free Cash Flow | -54.7 | -33.39 | -34.46 | -37.86 | -22.12 | -15.91 | Upgrade
|
| Free Cash Flow Per Share | -0.68 | -0.43 | -0.47 | -0.53 | -0.41 | -0.37 | Upgrade
|
| Gross Margin | 23.75% | 23.69% | 18.71% | 15.24% | 19.14% | 20.82% | Upgrade
|
| Operating Margin | -9.42% | -10.73% | -19.84% | -34.56% | -48.04% | -47.15% | Upgrade
|
| Profit Margin | 15.04% | -10.98% | -24.90% | -18.66% | -55.00% | -79.27% | Upgrade
|
| Free Cash Flow Margin | -20.36% | -13.43% | -15.30% | -25.91% | -32.93% | -31.49% | Upgrade
|
| EBITDA | -17.63 | -20.73 | -37.57 | -44.77 | -31.09 | -23.23 | Upgrade
|
| EBITDA Margin | -6.56% | -8.33% | -16.68% | -30.64% | -46.29% | -45.97% | Upgrade
|
| D&A For EBITDA | 7.67 | 5.96 | 7.11 | 5.73 | 1.17 | 0.6 | Upgrade
|
| EBIT | -25.3 | -26.69 | -44.68 | -50.5 | -32.26 | -23.82 | Upgrade
|
| EBIT Margin | -9.42% | -10.73% | -19.84% | -34.56% | -48.04% | -47.15% | Upgrade
|
| Advertising Expenses | - | 2.71 | 4.06 | 4.54 | - | 1.89 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.